- RecruitingPHASE2
Pharmacologic Treatment Augmentation in Chronic Depression
This study looks into new ways to treat severe, long-lasting depression when other treatments haven't worked. It tests ketamine and a type of therapy called CBASP, sometimes together, to see if they can help improve symptoms.
For: Major Depressive DisorderGermany - AuthorisedTherapeutic exploratory (Phase II)
Efficacy of Ketamine for the Prevention of Relapse in Patients with Opioid-Use Disorders (OUD)
This study is looking into whether a medicine called ketamine can help people with opioid use disorder (addiction to strong painkillers or drugs like heroin) stay off opioids and reduce their cravings. It's an early-stage study to see how well it works.
For: Opioid Use DisorderCyprus